Former Actavis Head Of M&A Joins Psychedelics Company As CEO

In an exclusive conversation, pharma veteran Doug Drysdale revealed he has joined psychedelics-focused life sciences company Cybin Corp. as CEO.

Read the full post on Forbes - Healthcare

Javier Hasse, Senior Contributor